Gene expression and genomic drift comparative analysis between patient-derived conditionally reprogrammed cells and original tumors

被引：0
|
作者：
Li, Jessica
Liu, Bonnie
Nakamura, Rin
Savage, Heidi
Ikeda, Shoji
Wilson, Timothy
Sumiyoshi, Teiko
Hampton, Garret
Amler, Lukas
Lackner, Mark
Huang, Shih-Min A.
Darbonne, Walter C.
机构：
来源：
CANCER RESEARCH | 2016年 / 76卷
关键词：
D O I：
10.1158/1538-7445.AM2016-4257
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4257
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Are the genomic gene expression profiles maintained between the original donor and patient-derived xenograft tumors
    Fernandez, Leopoldo J.
    Wolen, Aaron R.
    Olex, Amy L.
    Dozmorov, Mikhail
    Fenstermacher, David A.
    Takabe, Kazuaki
    CANCER RESEARCH, 2015, 75
  • [2] Patient-Derived Conditionally Reprogrammed Cells in Prostate Cancer Research
    Elbialy, Abdalla
    Kappala, Deepthi
    Desai, Dhruv
    Wang, Peng
    Fadiel, Ahmed
    Wang, Shang-Jui
    Makary, Mina S.
    Lenobel, Scott
    Sood, Akshay
    Gong, Michael
    Dason, Shawn
    Shabsigh, Ahmad
    Clinton, Steven
    Parwani, Anil V.
    Putluri, Nagireddy
    Shvets, Gennady
    Li, Jenny
    Liu, Xuefeng
    CELLS, 2024, 13 (12)
  • [3] Conditionally Reprogrammed Patient-derived Cells: A Step Forward Towards Personalized Medicine?
    Martini, Alberto
    Sfakianos, John P.
    Galsky, Matthew D.
    EUROPEAN UROLOGY, 2019, 76 (04) : 435 - 436
  • [4] Patient-derived conditionally reprogrammed cells maintain intra-tumor genetic heterogeneity
    Correa, Bruna R. S.
    Hu, Joanna
    Penalva, Luiz O. F.
    Schlegel, Richard
    Rimm, David L.
    Galante, Pedro A. F.
    Agarwal, Seema
    SCIENTIFIC REPORTS, 2018, 8
  • [5] Patient-derived conditionally reprogrammed cells maintain intra-tumor genetic heterogeneity
    Bruna R. S. Correa
    Joanna Hu
    Luiz O. F. Penalva
    Richard Schlegel
    David L. Rimm
    Pedro A. F. Galante
    Seema Agarwal
    Scientific Reports, 8
  • [6] Personalized Drug Sensitivity Screening for Bladder Cancer Using Conditionally Reprogrammed Patient-derived Cells
    Kettunen, Kimmo
    Bostrom, Peter J.
    Lamminen, Tarja
    Heinosalo, Taija
    West, Gun
    Saarinen, Irena
    Kaipio, Katja
    Rantala, Juha
    Albanese, Chris
    Poutanen, Matti
    Taimen, Pekka
    EUROPEAN UROLOGY, 2019, 76 (04) : 430 - 434
  • [7] Conditionally reprogrammed cells from patient-derived xenograft to model neuroendocrine prostate cancer development
    Ci, Xinpei
    Hao, Jun
    Dong, Xin
    Xue, Hui
    Wu, Rebecca
    Haegert, Anne M.
    Collins, Colin C.
    Lin, Dong
    Wang, Yuzhuo
    CANCER RESEARCH, 2019, 79 (13)
  • [8] Combining ATR inhibitors with carboplatin in chemoresistant TNBC conditionally reprogrammed cells and patient-derived xenografts
    Guay, Juliet
    MOLECULAR CANCER THERAPEUTICS, 2021, 20 (12)
  • [9] Conditionally Reprogrammed Cells from Patient-Derived Xenograft to Model Neuroendocrine Prostate Cancer Development
    Ci, Xinpei
    Hao, Jun
    Dong, Xin
    Xue, Hui
    Wu, Rebecca
    Choi, Stephen Yiu Chuen
    Haegert, Anne M.
    Collins, Colin C.
    Liu, Xuefeng
    Lin, Dong
    Wang, Yuzhuo
    CELLS, 2020, 9 (06)
  • [10] Comprehensive Drug Testing of Patient-derived Conditionally Reprogrammed Cells from Castration-resistant Prostate Cancer
    Saeed, Khalid
    Rahkama, Vesa
    Eldfors, Samuli
    Bychkov, Dmitry
    Mpindi, John Patrick
    Yadav, Bhagwan
    Paavolainen, Lassi
    Aittokallio, Tero
    Heckman, Caroline
    Wennerberg, Krister
    Peehl, Donna M.
    Horvath, Peter
    Mirtti, Tuomas
    Rannikko, Antti
    Kallioniemi, Olli
    Ostling, Paivi
    af Hallstrom, Taija M.
    EUROPEAN UROLOGY, 2017, 71 (03) : 319 - 327
12345